New research has the potential to transform the design of brain implants for neurological disorders, making them safer and ...

STRASBOURG, France; MONTREAL, Canada; BOSTON, MA, USA I March 20, 2025 I Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep ...

Research reveals how sugar consumption triggers addiction-like responses in the brain while increasing risk of diabetes and ...

Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response ...

Incyte's povorcitinib met key Phase 3 trial endpoints in hidradenitis suppurativa, showing significant clinical response and a well-tolerated safety profile.

Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...

In NYC, spring kicks off tree pollen season, followed by grass pollen in the summer and weed pollen in the late summer and ...

Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...

Sony’s It Ends With Us adapted Colleen Hoover’s powerful story about domestic violence and a resilient woman, but drama between stars Blake Lively and Justin Baldoni behind the scenes and afterwards ...

Scientists have identified a key component to launching immune activity – and overactivity. The researchers identified a ...

Explore the unexpected factors that may influence brain tumor risk and learn practical steps to protect your health and well-being.

Scientists at Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of ...